DRUG TRANSPORT IN THE LIVER - Drug Transporters: Molecular Characterization and Role in Drug Disposition - page 409

292. Belinsky MG, Dawson PA, Shchaveleva I, Bain LJ, Wang R, Ling V, Chen ZS, Grinberg
A, Westphal H, Klein-Szanto A, Lerro A, Kruh GD. 2005. Analysis of the in vivo
functions of Mrp3. Mol Pharmacol 68:160-168.
293. Lan LB, Dalton JT, Schuetz EG. 2000. Mdr1 limits CYP3A metabolism in vivo. Mol
Pharmacol 58:863-869.
294. Wang S, Hartley DP, Ciccotto SL, Vincent SH, Franklin RB, Kim MS. 2003. Induc-
tion of hepatic phase II drug-metabolizing enzymes by 1,7-phenanthroline in rats is
accompanied by induction of MRP3. Drug Metab Dispos 31:773-775.
295. Kim RB. 2004. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins)
and genetic variability (single nucleotide polymorphisms) in a hepatic drug uptake
transporter: what's it all about? Clin Pharmacol Ther 75:381-385.
296. Zhang L, Gorset W, Washington CB, Blaschke TF, Kroetz DL, Giacomini KM. 2000.
Interactions of HIV protease inhibitors with a human organic cation transporter in a
mammalian expression system. Drug Metab Dispos 28:329-334.
297. Schrenk D, Baus PR, Ermel N, Klein C, Vorderstemann B, Kauffmann HM. 2001.
Up-regulation of transporters of the MRP family by drugs and toxins. Toxicol Lett 120:
51-57.
298. Teng S, Jekerle V, Piquette-Miller M. 2003. Induction of ABCC3 (MRP3) by pregnane
X receptor activators. Drug Metab Dispos 31:1296-1299.
299. Johnson DR, Klaassen CD. 2002. Regulation of rat multidrug resistance protein 2 by
classes of prototypical microsomal enzyme inducers that activate distinct transcription
pathways. Toxicol Sci 67:182-189.
300. Turncliff RZ, Meier PJ, Brouwer KL. 2004. Effect of dexamethasone treatment on the
expression and function of transport proteins in sandwich-cultured rat hepatocytes. Drug
Metab Dispos 32:834-839.
301. Huang W, Zhang J, Chua SS, Qatanani M, Han Y, Granata R, Moore DD. 2003. Induction
of bilirubin clearance by the constitutive androstane receptor (CAR). Proc Natl Acad Sci
USA 100:4156-4161.
302. Chen C, Klaassen CD. 2004. Rat multidrug resistance protein 4 (Mrp4, Abcc4): molec-
ular cloning, organ distribution, postnatal renal expression, and chemical inducibility.
Biochem Biophys Res Commun 317:46-53.
303. Tanaka K, Xu W, Zhou F, You G. 2004. Role of glycosylation in the organic anion
transporter OAT1. J Biol Chem 279:14961-14966.
304. Tian X, Zamek-Gliszczynski MJ, Zhang P, Brouwer KL. 2004. Modulation of multidrug
resistance-associated protein 2 (Mrp2) and Mrp3 expression and function with small
interfering RNA in sandwich-cultured rat hepatocytes. Mol Pharmacol 66:1004-1010.
305. Oza AM. 2002. Clinical development of P glycoprotein modulators in oncology. Novartis
Found Symp 243:103-115.
306. Ros JE, Libbrecht L, Geuken M, Jansen PL, Roskams TA. 2003. High expression of
MDR1, MRP1, and MRP3 in the hepatic progenitor cell compartment and hepatocytes
in severe human liver disease. J Pathol 200:553-560.
307. Madon J, Hagenbuch B, Landmann L, Meier PJ, Stieger B. 2000. Transport function
and hepatocellular localization of mrp6 in rat liver. Mol Pharmacol 57:634-641.
308. Li L, Meier PJ, Ballatori N. 2000. Oatp2 mediates bidirectional organic solute transport:
a role for intracellular glutathione. Mol Pharmacol 58:335-340.